Webcast

The Team, the Team, the Team: Creating a Short Bowel Syndrome Medical Neighborhood

Launch Date
05/17/2022
Credit Amount
1.00 Hours
Credit Expires
04/27/2023

Faculty

Miguel Regueiro, MD, AGAF, FACG, FACP
Chair, Digestive Disease and Surgery Chair, Department of Gastroenterology, Hepatology, and Nutrition The Pier C. and Renee A. Borra Family Endowed Chair in Gastroenterology and Hepatology
Professor, Department of Medicine Cleveland Clinic Lerner College of Medicine of Case Western Reserve University Cleveland, OH
Miguel Regueiro, MD, AGAF, FACG, FACP

Miguel Regueiro earned his bachelor’s degree at the University of Pennsylvania, his medical degree at Drexel (Hahnemann) University and completed his internal medicine internship, residency, and clinical and research fellowship training in gastroenterology at Harvard Medical School’s Beth Israel Hospital.

Dr. Regueiro was Professor of Medicine and Clinical and Translational Science at the University of Pittsburgh School of Medicine from 2000 to 2018. There he served as the IBD Clinical Medical Director, Senior Medical Lead of Specialty Medical Homes, was Professor with Tenure, and honored as the UPMC Endowed Chair for Patient Centered Care in Inflammatory Bowel Diseases.

Dr. Regueiro is currently the Chair of the Department of Gastroenterology and Hepatology and Chair of the Digestive Disease and Surgery Institute at Cleveland Clinic in Ohio. He serves as Medical Co- Chair of Digestive Disease and Surgical Institute Research Governance committee and is Professor of Medicine at the Lerner College of Medicine, Cleveland Clinic.

Dr. Regueiro’s main clinical and research interest is Inflammatory Bowel Diseases with a focus on the natural course of these diseases and postoperative prevention of Crohn’s disease. Recently, he has been involved in transformative medicine initiatives and developing new models of healthcare, including the first-of-its kind specialty medical home for IBD. Dr. Regueiro is investigating alternative models of care in population-based health that integrates patients, payers, providers, pharmaceutical industry, and other facets of healthcare delivery around these novel programs.

Kishore R. Iyer, MBBS, FRCS (Eng), FACS
Director, Intestinal Rehab & Transplant Program
Program Director, Transplant Surgery Fellowship
Professor of Surgery & Pediatrics, Mount Sinai Medical Center, Icahn School of Medicine at Mount Sinai, New York, NY
Kishore R. Iyer, MBBS, FRCS (Eng), FACS

Dr. Iyer is Director of Adult and Pediatric Intestinal Rehabilitation & Transplantation at Mount Sinai Medical Center in New York, Surgical Director of Pediatric Liver Transplantation, and Professor of Surgery and Pediatrics at the Mount Sinai School of Medicine. He trained in general surgery and pediatric surgery in the UK where he worked with Dr. Adrian Bianchi and developed his early interest in short bowel syndrome and the use of intestinal lengthening procedures. He pursued research at the Great Ormond Street Hospital for Sick Children in London, winning the 1996 British Association of Pediatric Surgeons Prize for his pioneering work identifying phytosterols in soy-based lipid emulsions as a potential cause for parenteral nutrition-associated liver disease in patients with intestinal failure.

Dr. Iyer is a Fellow of the Royal College of Surgeons of England and a Fellow of the American College of Surgeons. He trained in transplant surgery in Chicago and Omaha, working as a liver and intestinal transplant surgeon in Omaha for almost 4 years. He was responsible for establishing and directing the intestinal rehabilitation program, the first of its kind nationally, in Omaha, before moving to Chicago to establish and direct the intestinal transplantation and rehabilitation program at Northwestern University/Children’s Memorial Hospital.

He serves on the Pediatric Committee and the Policy Oversight Committees of UNOS (United Network for Organ Sharing) and is Chair of the International Relations Committee of UNOS. He is also a past member of the Board of Trustees of the Oley Foundation, a large support group and information resource for patients with intestinal failure.

His current clinical and research interests are in the areas of surgical management of intestinal failure, intestinal transplant and TPN-associated liver disease, as well as in mathematical modeling for complex medical decision-making.

Donald F. Kirby, MD, FACP, FACN, FACG, AGAF, FASPEN, CNSC, CPNS
Professor of Medicine, Cleveland Clinic, Cleveland, OH
Director, Center for Human Nutrition
Medical Director, Intestinal Transplant Program
Donald F. Kirby, MD, FACP, FACN, FACG, AGAF, FASPEN, CNSC, CPNS

Dr. Kirby is a gastroenterologist who specializes in Nutrition at the Cleveland Clinic in Cleveland, Ohio. He is Board Certified in Internal Medicine, Gastroenterology and Nutrition Support. His practice encompasses from very malnourished patients, who may require enteral or intravenous nutrition, to those with morbid obesity. In addition, he is the Director for the Center for Human Nutrition, the Medical Director for the Intestinal Transplant Program, and a Professor of Medicine.

Explore By Section
Statement of Need Learning Objectives Financial Support Target Audience Credit Information Disclosure Declaration Additional Formats

Statement of Need

Although short bowel syndrome (SBS) remains a relatively rare disorder, the number of cases has doubled in the past 40 years. Due to this increased disease incidence and a projected shortage of gastroenterologists, an interdisciplinary approach is needed that is inclusive of primary care physicians, PAs, and nurse practitioners who are likely to be recruited to care for this patient population.

In this CME Outfitters Live and OnDemand webcast, expert faculty in SBS will discuss integrating an interdisciplinary team to optimize the management of patients with SBS, with a focus on applying efficacy and safety data to treatment decision-making and implementing best practices from state-of-the-art intestinal rehabilitation centers in the community to improve access and care.

Learning Objectives

At the end of this CME/CE activity, participants should be able to:

  • Integrate an interdisciplinary team to optimize the management of patients with SBS.
  • Apply efficacy and safety data to treatment decision-making for patients with SBS.
  • Implement best practices from state-of-the-art SBS/IR centers in the community to improve access and care for patients with SBS.

Financial Support

Supported by an educational grant from Takeda Pharmaceuticals, U.S.A., Inc.

Target Audience

Gastroenterologists, surgeons, pediatricians, internists, primary care physicians, PAs, nurse practitioners, nurses, pharmacists, social workers, dietitians, psychologists, and feeding therapists

Credit Information

Jointly Accredited Provider

In support of improving patient care, CME Outfitters, LLC, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians (ACCME)

CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. CME Outfitters, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Surgeons (ABS CC)

Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME and/or Self-Assessment requirements of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit

Pediatricians (ABP MOC)

Successful completion of this CME activity, which includes participation in the activity and individual assessment of and feedback to the learner, enables the learner to earn up to 1.0 MOC point in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABP MOC credit.

Nurses (ANCC)

This activity is designated for 1.0 contact hour. Nurse practitioners can apply for AMA PRA Category 1 Credit(s)™ through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 Credit(s)™ from Jointly Accredited Organizations. Nurse practitioners can also apply for credit through their state boards.

Pharmacists (ACPE)

This application-based activity is approved for 1.0 contact hour (0.10 CEUs) of continuing pharmacy credit. Jump to Activity UAN.
Activity UAN: 0376-0000-21-062-H02-P

PAs (AAPA)

CME Outfitters, LLC, has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. Approval is valid until the expiration date listed above. PAs should only claim credit commensurate with the extent of their participation.

ABPN MOC

ABPN Diplomates may select any CME activity relevant to their practice to count towards ABPN MOC requirements.

Note to Nurse Practitioners

Nurse Practitioners can apply for AMA PRA Category 1 Credit ™ through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 Credit ™ from organizations accredited by the Accreditation Council for Continuing Medical Education. Nurse practitioners can also apply for credit through their state boards.

California Residents

This continuing nursing education activity was approved by the California Board of Registered Nursing. CME Outfitters LLC’s provider number is CEP15510.

Dietetics (CDR)

Completion of this RD/DTR profession-specific or IPCE activity awards CPEUs (One IPCE credit = One CPEU). If the activity is dietetics-related but not targeted to RDs or DTRs, CPEUs may be claimed which are commensurate with participation in contact hours (One 60 minute hour = 1 CPEU). RDs and DTRs are to select activity type 102 in their Activity Log. Performance indicator selection is at the learner’s discretion.

Interprofessional (IPCE)

This activity was planned by and for the healthcare team, and learners will receive 1.5 Interprofessional Continuing Education (IPCE) credit for learning and change.

Royal College MOC

Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

MIPS Improvement Activity

This activity counts towards MIPS Improvement Activity requirements under the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.

Disclosure Declaration

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations. [Hard return + divider]

Dr. Regueiro reports the following financial relationships: Advisory Board and Consultant: AbbVie Inc.; Alfasigma, S.p.A.; Allergan; Amgen Inc.; Celgene Corporation; Genentech, Inc.; Gilead Sciences, Inc.; Janssen Pharmaceuticals, Inc.; Lilly; Miraca Laboratories; Pfizer Inc.; Prometheus Biosciences; Salix Pharmaceuticals; Seres Therapeutics; Takeda Pharmaceuticals U.S.A., Inc.; TARGET PharmaSolutions, Inc.; and UCB, Inc. Research Support: AbbVie Inc.; Janssen Pharmaceuticals, Inc.; Pfizer Inc.; and Takeda Pharmaceuticals U.S.A., Inc. Royalties: Wolters Kluwer Health as Author/Editor of UpToDate. Unrestricted Educational Grants: AbbVie Inc.; Celgene Corporation; Genentech, Inc.; Gilead Sciences, Inc.; Janssen Pharmaceuticals, Inc.; Pfizer Inc.; Takeda Pharmaceuticals U.S.A., Inc.; and UCB, Inc.

Dr. Iyer reports the following financial relationships: Consultant: Hanmi Pharmaceutical, Co., Ltd.; Ipsen Pharma; Takeda Pharmaceuticals U.S.A., Inc.; and VectivBio. Grants:Takeda Pharmaceuticals U.S.A. Research Support:Takeda Pharmaceuticals U.S.A.; VectivBio; and Zealand Pharma A/S.

Dr. Kirby reports the following financial relationships: Advisory Board: OWYN, Inc.; Takeda Pharmaceuticals U.S.A., Inc.; and VectivBio.

Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.

  • Jeffrey Helfand, DO (peer reviewer)
  • Kasey Brandt, PharmD (planning committe)
  • Susan Perry (planning committee)
  • Susan H. Yarbrough, CHCP (planning committee)
  • Sharon Tordoff (planning committee)

Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

Additional Formats

Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (75% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit our Privacy & Confidentiality page.

 

NOTE: Pharmacist CE Universal Activity Number, Enduring: 0376-0000-21-062-H02-P.

Questions about this activity?

Call us at 877.CME.PROS (877.263.7767).

TV-129-042622-20

Related Activities

Diversity & Inclusion
03/03/2023

Gastroenterology Care: Real-World Tactics to Address Health Inequities

1.00 Hours
Begin Learn More
Gastroenterology
01/25/2021

Unique Approaches to the Management of Underserved Patients with IBD

0.00 Expired
Begin Learn More
Gastroenterology
01/12/2021

The Role of Socioeconomic Factors in Health Care Delivery in IBD

0.00 Expired
Begin Learn More
The Team, the Team, the Team: Creating a Short Bowel Syndrome Medical Neighborhood
Event Date: 05/17/2022
Begin